Alternatives
Alternatives to Bioverse
Bioverse scores 56/100 on our Cost-Efficiency Index . Here are other programs to consider, each scored the same way. Partners are listed first.
Bioverse at a glance
- Semaglutide
- $129/moStarting dose, 6-month plan paid upfront, compounded
- Tirzepatide
- $399/moStarting price, compounded
- Coverage
- 18 states
- Brand-name GLP-1s
- Yes
- Oral option
- No
- Pricing verified
- October 2026
3 of the 8 programs below list semaglutide for less than Bioverse's $129 a month. 6 of the 8 list tirzepatide for less than its $399 a month.
Bioverse is a GLP-1 telehealth brand serving 18 named states, with compounded semaglutide from $129 a month on a 6-month plan paid upfront and compounded tirzepatide from $399.
Best for: Shoppers in one of Bioverse's 18 states who are willing to pay six months upfront for the lowest semaglutide rate.
What Bioverse does well
- Publishes the 18 states it serves
- Starting prices for both semaglutide and tirzepatide are on the product pages
- Displays a LegitScript seal
- Also sells brand-name Ozempic and lower-cost oral medication kits
Why readers look for an alternative
- The $129 semaglutide price requires paying for a 6-month plan upfront
- Tirzepatide starts at $399 a month
- Only serves 18 states, and a second list on the site shows 10
- Calls its compounded drugs 'FDA compliant', though they aren't FDA-approved
- All sales are final; cancel at least 48 hours before an order is processed
- FDA issued Bioverse, Inc. dba Bioverse a warning letter in September 2025; the letter is public in FDA's warning-letter database
- Partner01A94/ 100Index
CoreAge Rx
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- All 50 states
- Brand
- Compounded
Compared with Bioverse: $30/mo less for semaglutide · $250/mo less for tirzepatide · compounded only, no brand-name GLP-1s
- 02C57/ 100Index
LumiMeds
LumiMeds is a telehealth platform selling compounded semaglutide 'as low as $89/mo' and compounded tirzepatide 'as low as $125/mo' on fixed-term monthly, 3-, 6- and 12-month plans, with Klarna financing.
- Sema
- $89/moAs low as, fixed-term plan, plan length not stated, compounded; first month as low as $39
- Tirz
- $125/moAs low as, fixed-term plan, plan length not stated, compounded; first month as low as $75
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Bioverse: $40/mo less for semaglutide · $274/mo less for tirzepatide · compounded only, no brand-name GLP-1s
Regulatory note: the FDA issued a warning letter to Lumimeds in September 2025. We still list and link to LumiMeds; you should know the letter is on the public record before you decide.
- 03C57/ 100Index
Emerge Weight Loss
Emerge Weight Loss is a compounded-tirzepatide-only telehealth provider (no semaglutide) with dose-tiered 4-week pricing from $224 to $289 for injectable vials, plus a $149/month oral tablet option.
- Sema
- Not disclosed
- Tirz
- $224 per 4 weeks2.5 mg starting dose, compounded
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Bioverse: $175/mo less for tirzepatide · compounded only, no brand-name GLP-1s · offers an oral option
- 04C57/ 100Index
Refills
Refills is a multi-category telehealth platform offering compounded GLP-1 treatment through independent clinician networks, with Hallandale and Perfect Rx named as dispensing partners.
- Sema
- Not disclosed
- Tirz
- Not disclosed
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Bioverse: compounded only, no brand-name GLP-1s
Regulatory note: the FDA issued a warning letter to Refills Health, LLC dba Refills Health in February 2026. We still list and link to Refills; you should know the letter is on the public record before you decide.
- 05C57/ 100Index
Framework
Framework offers doctor-guided compounded GLP-1 plans with nutrition support, while the medication price appears after intake.
- Sema
- Not disclosed
- Tirz
- Not disclosed
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Bioverse: compounded only, no brand-name GLP-1s
- 06C56/ 100Index
HelloWellness
HelloWellness sells compounded GLP-1 plans paid up front and renewed every 11 weeks, so its advertised three-month equivalents understate the ongoing calendar-month average.
- Sema
- ~$157.18/mo equivalent average ($399 upfront, then every 11 weeks; compounded)
- Tirz
- ~$196.58/mo equivalent average ($499 upfront, then every 11 weeks; compounded; cadence conflict)
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Bioverse: $28.18/mo more for semaglutide · $202.42/mo less for tirzepatide · compounded only, no brand-name GLP-1s
- 07C56/ 100Index
Vita Bella
Vita Bella is a broad multi-category telehealth platform bundling GLP-1 weight loss with hormone therapy, sexual wellness, and anti-aging treatments under one $129/mo membership.
- Sema
- $109/moPlus a separate fee, compounded
- Tirz
- $159/moPlus a separate fee, compounded
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Bioverse: $20/mo less for semaglutide · $240/mo less for tirzepatide · compounded only, no brand-name GLP-1s
- 08C56/ 100Index
Joi + Blokes
Joi + Blokes is a hormone-first telehealth platform running parallel women's (Joi) and men's (Blokes) programs, with compounded GLP-1s at $179/mo semaglutide and $249/mo tirzepatide (after a discounted $99/$149 first month) and a separate brand Zepbound program.
- Sema
- $179/moBilled quarterly, first month $99, compounded
- Tirz
- $249/moBilled quarterly, first month $149, compounded
- Coverage
- Multi-state
- Brand
- Yes
Compared with Bioverse: $50/mo more for semaglutide · $150/mo less for tirzepatide
Regulatory note: the FDA issued a warning letter to Joi and Blokes dba Joi + Blokes in June 2026. We still list and link to Joi + Blokes; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — it never changes the Cost-Efficiency Index. Pricing and coverage reflect public disclosures at last review; confirm on each provider's site. Not medical advice. See our disclosure.